Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Z2JN
|
|||
Former ID |
DNC013210
|
|||
Drug Name |
N1,2-dibenzyl-N3-hydroxymalonamide
|
|||
Synonyms |
CHEMBL113827; N1,2-dibenzyl-N3-hydroxymalonamide; 2N-dibenzyl-N''-hydroxy-malonamide; BDBM50062474
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H18N2O3
|
|||
Canonical SMILES |
C1=CC=C(C=C1)CC(C(=O)NCC2=CC=CC=C2)C(=O)NO
|
|||
InChI |
1S/C17H18N2O3/c20-16(18-12-14-9-5-2-6-10-14)15(17(21)19-22)11-13-7-3-1-4-8-13/h1-10,15,22H,11-12H2,(H,18,20)(H,19,21)
|
|||
InChIKey |
WKIMWNKNDQXNCK-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Aminopeptidase N (ANPEP) | Target Info | Inhibitor | [1] |
BioCyc | Glutathione-mediated detoxification | |||
KEGG Pathway | Glutathione metabolism | |||
Metabolic pathways | ||||
Renin-angiotensin system | ||||
Hematopoietic cell lineage | ||||
Pathwhiz Pathway | Glutathione Metabolism | |||
Pathway Interaction Database | C-MYB transcription factor network | |||
Reactome | Metabolism of Angiotensinogen to Angiotensins | |||
WikiPathways | Metabolism of Angiotensinogen to Angiotensins | |||
Cardiac Progenitor Differentiation | ||||
miR-targeted genes in squamous cell - TarBase | ||||
miR-targeted genes in muscle cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase | ||||
miR-targeted genes in leukocytes - TarBase | ||||
Glutathione metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents. J Med Chem. 2007 Mar 22;50(6):1322-34. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.